Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Decrease in plasma adiponectin concentrations in patients with variant angina pectoris.

Soon Jun Hong1, Hong Seog Seo, Seung Woon Rha

  • 1Department of Cardiology, Cardiovascular Center, Korea University Guro Hospital, Seoul.

Circulation Journal : Official Journal of the Japanese Circulation Society
|March 28, 2006
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

De-escalation from prasugrel to clopidogrel at the 12-month landmark after percutaneous coronary intervention with drug-eluting stents for acute myocardial infarction: a Korea Acute Myocardial Infarction Registry-National Institutes of Health cohort study.

Coronary artery disease·2026
Same author

Voice features and deep learning models for identifying acute decompensated heart failure.

Digital health·2026
Same author

Prognostic significance of high Lipoprotein(a) levels in patients with coronary artery spasm.

Heart and vessels·2026
Same author

Risk of new-onset diabetes across individual statins in secondary prevention: results from the Korean national health insurance service cohort.

Frontiers in cardiovascular medicine·2026
Same author

Effectiveness and Safety of Biodegradable Polymer-Coated Everolimus-Eluting Stent in Multivessel Coronary Artery Disease in Routine Clinical Practice: A Korean Multicenter, Prospective, and Observational Study.

Journal of Korean medical science·2026
Same author

Optimizing duration of renin-angiotensin system inhibition after ST-elevation myocardial infarction with drug-eluting stent-percutaneous coronary intervention: Real-World Landmark Evidence from the Korea Acute Myocardial Infarction Registry-National Institutes of Health Registry.

Coronary artery disease·2026

Low plasma adiponectin levels are linked to variant angina pectoris (VAP). This study found reduced adiponectin in VAP patients compared to healthy controls, suggesting a potential association with VAP development.

Area of Science:

  • Cardiology
  • Endocrinology
  • Biochemistry

Background:

  • Plasma adiponectin is reduced in coronary artery diseases, particularly acute coronary syndrome (ACS).
  • The relationship between plasma adiponectin and variant angina pectoris (VAP) remains unverified.
  • This study aimed to compare adiponectin levels in VAP with other coronary artery diseases.

Purpose of the Study:

  • To compare plasma adiponectin concentrations in patients with VAP versus ACS, stable angina, and healthy controls.
  • To investigate the association between plasma adiponectin levels and the development of VAP.

Main Methods:

  • Plasma adiponectin concentrations were measured in VAP (n=101), ACS (n=117), stable angina (n=108), and normal coronary (n=81) groups.
  • Statistical comparisons were made between groups.

Related Experiment Videos

  • Multivariate analysis was employed to identify independent predictors of VAP.

    • Main Results:

    • Plasma adiponectin levels were significantly lower in VAP and ACS groups compared to the normal coronary group (p<0.001).
    • Multivariate analysis revealed that lower plasma adiponectin (OR 0.735), smoking (OR 2.012), and age (OR 0.976) were independently associated with VAP development.
    • Plasma adiponectin showed a significant inverse correlation with VAP development.

    Conclusions:

    • Decreased plasma adiponectin concentration is potentially associated with the development of variant angina pectoris.
    • Adiponectin may serve as a biomarker for VAP risk assessment.
    • Further research is warranted to elucidate the precise role of adiponectin in VAP pathogenesis.